LFB Biomanufacturing

keyboard_backspaceBack to Home

Contact

location_on

impasse des Chênes Rouges
30100 ALES
France

David Balbuena
Director of Business Development

About us

LFB Biomanufacturing (Alès- South of France) is a French CDMO belonging to LFB Group, with scalable capacities that will adapt to the different clinical phases of your project.

we have 25 years of experience in development and manufacturing of therapeutic proteins, a solid track record, including ANSM and FDA certifications. We can provide Drug conjugation with preferred subcontractors.

Our current customers appreciate our agility, our reliability and qualify our services as very competitive. 

 

sales-lfb-biomanufacturing@lfb.fr

Business offer

LFB Biomanufacturing is a Contract Development and Manufacturing Organization (CDMO), located in Ales, belonging to LFB Group, and acting in the field of monoclonal antibodies and recombinant proteins. 
It can provide services using mammalian cell capabilities up to 2000L in single use technology with most common recombinant mammalian cell lines such as CHO. Moreover, LFB Biomanufacturing can propose the EMABling® platform using the proprietary YB2/0-E cell line to produce recombinant monoclonal antibodies having an enhanced antibody-dependent cellular cytotoxicity (ADCC) activity due to a specific glycosylation pattern. Should you have any question or needs for a discussion or visit of our facilities (Alès- South of France), Please feel free to contact us.

Activities

    Categories

    • Service

    Therapeutic applications

    • Oncology
    • Immunology

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • CMC
    • GLP compliance
    • GLP compliance
    • Master Cell Bank
    • Production
    • Cell Line development
    • Clone selection
    • Characterization
    • Storage
    • Analytical development
    • Cell Culture
    • Media composition
    • Bioreactor conditions
    • Bioproduction
    • Batches production type
    • Mammalian
    • GLP compliance
    • GMP compliance
    • Pilot Batches
    • Tests
    • Optimization
    • Scale-Up process
    • Process optimization & validation
    • Volume
    • Preclinical / Tox
    • Low volume (< 200 L)
    • High volume (200 – 2000 L)
    • Very high volume (> 2000 L)
    • Commercial
    • USP (Scale-Up)
    • Cell expansion
    • Inoculation
    • Low volume containers to Bioreactors
    • DSP (Recovery)
    • Harvest
    • Filtration
    • Purification
    • Fill & Finish
    • Aseptic filling
    • Lyophilization
    • Batch release
    • Cell cryopreservation
    • Controlled-rated freezer
    • thaw
    • Quality assurance, quality control & analytical process
    • Stability Assessment
    • Physical & chemical profile
    • Shear/shaking
    • Viscosity
    • Photostability
    • pH
    • Freeze/thaw
    • Heat/degradation
    • Aggregation
    • Cell line analytical development
    • Host cell proteins
    • Viral clearance
    • Contaminants detection
    • Biosafety & Bioanalysis
    • Impurities detection
    • Bioproduction analytical test
    • Monitoring
    • Characterization
    • Batch consistency
    • Batch release test
    • Chemical, physical, biological test
    • Quality control test support
    • Post-production test
    • Real-time stability test
    • Formulation
    • Formulation
    • Stability
    • Excipients
    • Lyophilization
Français English